ZIRA Trademark

Trademark Overview

On Friday, May 9, 2008, a trademark application was filed for ZIRA with the United States Patent and Trademark Office. The USPTO has given the ZIRA trademark a serial number of 77469940. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 22, 2012. This trademark is owned by Glaxo Group Limited. The ZIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines; excluding psychiatric and depressant related diseases and disorders
zira

General Information

Serial Number77469940
Word MarkZIRA
Filing DateFriday, May 9, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 22, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines; excluding psychiatric and depressant related diseases and disorders
Translation of Words in MarkThe wording "ZIRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 13, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN

Trademark Events

Event DateEvent Description
Monday, October 22, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 22, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, March 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2012EXTENSION 5 GRANTED
Monday, March 12, 2012EXTENSION 5 FILED
Monday, March 12, 2012TEAS EXTENSION RECEIVED
Saturday, September 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 2, 2011EXTENSION 4 GRANTED
Monday, August 29, 2011EXTENSION 4 FILED
Monday, August 29, 2011TEAS EXTENSION RECEIVED
Thursday, March 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2011EXTENSION 3 GRANTED
Thursday, February 17, 2011EXTENSION 3 FILED
Thursday, February 17, 2011TEAS EXTENSION RECEIVED
Tuesday, September 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 20, 2010EXTENSION 2 GRANTED
Friday, August 20, 2010EXTENSION 2 FILED
Wednesday, September 15, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 20, 2010TEAS EXTENSION RECEIVED
Friday, May 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 25, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 16, 2010EXTENSION 1 GRANTED
Tuesday, February 16, 2010EXTENSION 1 FILED
Tuesday, February 16, 2010TEAS EXTENSION RECEIVED
Tuesday, September 22, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 7, 2009EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 30, 2009CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, June 29, 2009ASSIGNED TO PETITION STAFF
Wednesday, June 3, 2009TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, April 23, 2009EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Thursday, February 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2009ASSIGNED TO LIE
Wednesday, February 4, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 25, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2008NON-FINAL ACTION E-MAILED
Monday, August 25, 2008NON-FINAL ACTION WRITTEN
Monday, August 25, 2008ASSIGNED TO EXAMINER
Tuesday, May 13, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

zira disorders diseases pharmaceutical treatment preparations substances related psychiatric dermatological hormonal